Overview

• The recall covers two batches—2312010 and 2312011—of Paracetamol 500 mg tablets packaged in 100-tablet pots with expiry dates of November 30 and 31, 2027, distributed in April and May 2025.
• The MHRA has classified the action as a Class 2 recall, indicating a defect that could cause mistreatment or harm without life-threatening risk.
• Patients are urged to inspect their medication immediately and contact a pharmacist or healthcare professional if they find any discoloured tablets.
• Pharmacists have been instructed to quarantine all remaining stock of the affected batches and return it to the supplier using approved protocols.
• Previous discolouration incidents have been linked to fungal contamination such as Penicillium citrinum, though the specific cause in these batches is still under investigation.